communicating risks and benefits

Download Book Communicating Risks And Benefits in PDF format. You can Read Online Communicating Risks And Benefits here in PDF, EPUB, Mobi or Docx formats.

Communicating Risks And Benefits

Author : Baruch Fischhoff
ISBN : 0160901790
Genre : Health & Fitness
File Size : 60. 34 MB
Format : PDF, ePub, Docs
Download : 603
Read : 353

Download Now


Effective risk communication is essential to the well-being of any organization and those people who depend on it. Ineffective communication can cost lives, money and reputations. Communicating Risks and Benefits: An Evidence-Based User’s Guide provides the scientific foundations for effective communications. The book authoritatively summarizes the relevant research, draws out its implications for communication design, and provides practical ways to evaluate and improve communications for any decision involving risks and benefits. Topics include the communication of quantitative information and warnings, the roles of emotion and the news media, the effects of age and literacy, and tests of how well communications meet the organization’s goals. The guide will help users in any organization, with any budget, to make the science of their communications as sound as the science that they are communicating.

Communicating Risks And Benefits

Author :
ISBN : OCLC:747104726
Genre : Evidence-based medicine
File Size : 82. 31 MB
Format : PDF, Mobi
Download : 796
Read : 483

Download Now


"Effective risk communication is essential to the well-being of any organization and those people who depend on it. Ineffective communication can cost lives, money, and reputations. Communicating Risks and Benefits: An Evidence-Based User's Guide provides the scientific foundations for effective communication."--FDA website.

Interpreting Health Benefits And Risks

Author : Eric Rifkin
ISBN : 9783319115443
Genre : Medical
File Size : 24. 65 MB
Format : PDF, Mobi
Download : 665
Read : 938

Download Now


This timely guide to communication in patient-centered medicine argues for greater clarity in explaining health risks versus benefits of an array of screening tests, procedures, and drug regimens. It reviews the growing trend toward patients' involvement in their own care, particularly in terms of chronic conditions, and details approaches physicians can use to prepare patients (and themselves) for collaborative decision-making based on informed choices and clear, meaningful knowledge. Chapters apply this lens to a wide range of common interventions as contentious as estrogen replacement therapy and antibiotics, and as widely prescribed as the daily aspirin and the annual physical. With this goal in mind, the authors also introduce an innovative decision-making tool that translates risks and benefits into a clear graphic format for fewer chances of miscommunication or misunderstanding. Among the topics covered: Involving the patient in decision making. Towards a universal decision aid. BRCT: the Benefit/Risk Characterization Theater. Breast Cancer Screening—Mammograms. Prostate Cancer Screening. Colon cancer screening with colonoscopy. Screening for and treating dementia. Statins, cholesterol, and coronary heart disease. Physicians in family and internal medicine will find Interpreting Health Benefits and Risks: A Practical Guide to Facilitate Doctor- Patient Communication a valuable resource for communicating with patients and new possibilities for working toward their better health and health education. This book considers several common and important situations where faulty decision-making makes overtreatment a serious risk. Clear, fair, referenced, and useful information is provided. And a powerful intuitive technique is introduced which allows patient and doctor to talk as equals as they work together in the exam room. The authors emphasize that some patients who have been fully educated will still accept high risks of harm for a small chance of avoiding premature death. But as this book is accepted and its ideas and technique are extended, I feel sure that net harm to patients will be curtailed. And what is more, the integrity of the decision-making process will be improved. —Thomas Finucane, MD, Professor of Medicine, Division of Gerontology and Geriatric Medicine, The Johns Hopkins University School of Medicine

Characterizing And Communicating Uncertainty In The Assessment Of Benefits And Risks Of Pharmaceutical Products

Author : Institute of Medicine
ISBN : 9780309310031
Genre : Medical
File Size : 84. 79 MB
Format : PDF
Download : 229
Read : 1080

Download Now


Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and limitations in the research and clinical trial process itself that might limit the generalizability of results. As a result, regulatory reviewers are consistently required to draw conclusions about a drug's safety and efficacy from imperfect data. Efforts are underway within the drug development community to enhance the evaluation and communication of the benefits and risks associated with pharmaceutical products, aimed at increasing the predictability, transparency, and efficiency of pharmaceutical regulatory decision making. Effectively communicating regulatory decisions necessarily includes explanation of the impact of uncertainty on decision making. On February 12 and May 12, 2014, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held public workshops to advance the development of more systematic and structured approaches to characterize and communicate the sources of uncertainty in the assessment of benefits and risks, and to consider their implications for pharmaceutical regulatory decisions. Workshop presentations and discussions on February 12 were convened to explore the science of identifying and characterizing uncertainty in scientific evidence and approaches to translate uncertainties into decisions that reflect the values of stakeholders. The May 12 workshop presentations and discussions explored tools and approaches to communicating about scientific uncertainties to a range of stakeholders in the drug development process. Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products summarizes the presentation and discussion of both events. This report explores potential analytical and communication approaches and identifies key considerations on their development, evaluation, and incorporation into pharmaceutical benefit- risk assessment throughout the entire drug development lifecycle.

Risk Communication And Health Psychology

Author : Berry, Dianne
ISBN : 9780335213511
Genre : Psychology
File Size : 58. 80 MB
Format : PDF, ePub
Download : 220
Read : 505

Download Now


This is the first book to clearly assess the increasingly important area of communication of risk in the health sector. We are moving away from the days when paternalistic doctors managed healthcare without involving patients in decision making. With the current emphasis on patient empowerment and shared decision making, patients want and need reliable, comprehensive and understandable information about their conditions and treatment. In order to make informed decisions, the people concerned must understand the risks and benefits associated with possible treatments. But the challenge for health professionals is how best to communicate this complex medical information to diverse audiences.

Risk Communication And Health Psychology

Author : Dianne Berry
ISBN : 9780335224265
Genre : Medical
File Size : 22. 68 MB
Format : PDF, Kindle
Download : 261
Read : 1265

Download Now


"...this text...will become a reference for years to come." Health Expectations This is the first book to clearly assess the increasingly important area of communication of risk in the health sector. We are moving away from the days when paternalistic doctors managed healthcare without involving patients in decision making. With the current emphasis on patient empowerment and shared decision making, patients want and need reliable, comprehensive and understandable information about their conditions and treatment. In order to make informed decisions, the people concerned must understand the risks and benefits associated with possible treatments. But the challenge for health professionals is how best to communicate this complex medical information to diverse audiences.The book examines: Risk: defining and explaining how the term is used by different disciplines, how its meanings have changed over time and how the general public understand it Health communication and the effects on health behaviours Effective risk communication to individuals and the wider public Effectiveness of patient information leaflets, and strategies for improving oral and written health communications The cognitive and emotional issues at stake for patients in understanding risk and health information The use of new technologies in risk and health communication Ethical issues, and the future of risk communication Using examples from disciplines including psychology, sociology, health, medicine, pharmacy, statistics and business and management, this book is key reading for students who need to understand the effect of risk in health psychology as well as for health professionals interested in doctor-patient communication, informed consent and patient welfare.

Vaccinophobia And Vaccine Controversies Of The 21st Century

Author : Archana Chatterjee
ISBN : 9781461474388
Genre : Medical
File Size : 72. 24 MB
Format : PDF, Docs
Download : 426
Read : 1325

Download Now


Vaccinophobia and Vaccine Controversies of the 21st Century Archana Chatterjee, editor Once hailed as a medical miracle, vaccination has come under attack from multiple fronts, including occasionally from within medicine. And while the rates of adverse reactions remain low, suggestions that vaccines can cause serious illness (and even death) are inspiring parents to refuse routine immunizations for their children--ironically, exposing them and others to potentially serious illness. Vaccinophobia and Vaccine Controversies of the 21st Century explains clearly how this state of affairs came into being, why it persists, and how healthcare professionals can best respond. Current findings review answers to bedrock questions about known adverse events, what vaccine additives are used for, and real and perceived risks involved in immunization. Perspectives representing pediatricians, family practitioners, nurses, parents, pharmacy professionals, the CDC, and the public health community help the reader sort out legitimate from irrational concerns. In-depth analyses discuss the possibility of links with asthma, cancer, Guillain-Barre syndrome, SIDS, and, of course, autism. Included in the coverage: Communicating vaccine risks and benefits The vaccine misinformation landscape in family medicine Perceived risks from live viral vaccines The media's role in vaccine misinformation Autoimmunity, allergies, asthma, and a relationship to vaccines Vaccines and autism: the controversy that won't go away The conundrums described here are pertinent to practitioners in pediatrics, family medicine, primary care, and nursing to help families with informed decision making. In addition, Vaccinophobia and Vaccine Controversies of the 21st Century should be read by trainees and researchers in child development and maternal and child health as the book's issues will have an impact on future generations of children and their families.

Communicating Risks To The Public

Author : R.E Kasperson
ISBN : 9789400919525
Genre : Technology & Engineering
File Size : 27. 88 MB
Format : PDF, Kindle
Download : 467
Read : 1309

Download Now


Risk communication: the evolution of attempts Risk communication is at once a very new and a very old field of interest. Risk analysis, as Krimsky and Plough (1988:2) point out, dates back at least to the Babylonians in 3200 BC. Cultures have traditionally utilized a host of mecha nisms for anticipating, responding to, and communicating about hazards - as in food avoidance, taboos, stigma of persons and places, myths, migration, etc. Throughout history, trade between places has necessitated labelling of containers to indicate their contents. Seals at sites of the ninth century BC Harappan civilization of South Asia record the owner and/or contents of the containers (Hadden, 1986:3). The Pure Food and Drug Act, the first labelling law with national scope in the United States, was passed in 1906. Common law covering the workplace in a number of countries has traditionally required that employers notify workers about significant dangers that they encounter on the job, an obligation formally extended to chronic hazards in the OSHA's Hazard Communication regulation of 1983 in the United States. In this sense, risk communication is probably the oldest way of risk manage ment. However, it is only until recently that risk communication has attracted the attention of regulators as an explicit alternative to the by now more common and formal approaches of standard setting, insuring etc. (Baram, 1982).

Characterizing And Communicating Uncertainty In The Assessment Of Benefits And Risks Of Pharmaceutical Products

Author : Institute of Medicine
ISBN : 9780309310031
Genre : Medical
File Size : 60. 71 MB
Format : PDF, Mobi
Download : 328
Read : 335

Download Now


Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and limitations in the research and clinical trial process itself that might limit the generalizability of results. As a result, regulatory reviewers are consistently required to draw conclusions about a drug's safety and efficacy from imperfect data. Efforts are underway within the drug development community to enhance the evaluation and communication of the benefits and risks associated with pharmaceutical products, aimed at increasing the predictability, transparency, and efficiency of pharmaceutical regulatory decision making. Effectively communicating regulatory decisions necessarily includes explanation of the impact of uncertainty on decision making. On February 12 and May 12, 2014, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held public workshops to advance the development of more systematic and structured approaches to characterize and communicate the sources of uncertainty in the assessment of benefits and risks, and to consider their implications for pharmaceutical regulatory decisions. Workshop presentations and discussions on February 12 were convened to explore the science of identifying and characterizing uncertainty in scientific evidence and approaches to translate uncertainties into decisions that reflect the values of stakeholders. The May 12 workshop presentations and discussions explored tools and approaches to communicating about scientific uncertainties to a range of stakeholders in the drug development process. Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products summarizes the presentation and discussion of both events. This report explores potential analytical and communication approaches and identifies key considerations on their development, evaluation, and incorporation into pharmaceutical benefit- risk assessment throughout the entire drug development lifecycle.

Health And Environment Communicating The Risks

Author : Organisation mondiale de la santé. Bureau régional de l'Europe
ISBN : 9289000511
Genre :
File Size : 62. 11 MB
Format : PDF, Kindle
Download : 927
Read : 733

Download Now



Top Download:

Best Books